Filing Details

Accession Number:
0000885590-11-000057
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-08-15 18:56:28
Reporting Period:
2011-08-11
Filing Date:
2011-08-15
Accepted Time:
2011-08-15 18:56:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885590 Valeant Pharmaceuticals International Inc. VRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1426004 Michael J. Pearson 7150 Mississauga Road
Mississauga A6 L5N8M5
Chief Executive Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, No Par Value Acquisiton 2011-08-11 155,642 $38.62 5,570,503 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This number represents the weighted average purchase price with ranges purchased from $38.51 to $38.89.
  2. This number represents common shares purchased by the officer, common shares received upon settlement and/or exercise of previously granted equity awards, as well as other outstanding equity awards that were previously reported in Table 1.